Closed System Drug Transfer Device Market Size, Share, Growth and Forecast 2035

The Closed System Drug Transfer Device Market is experiencing strong growth as healthcare facilities increasingly prioritize the safe handling of hazardous drugs. Closed system drug transfer devices (CSTDs) are designed to minimize exposure to hazardous drug vapors, aerosols, and contaminants during preparation and administration. According to Market Research Future, the market was valued at USD 1.52 billion in 2025 and is projected to reach USD 5.42 billion by 2035, representing a CAGR of 13.6%.

Increasing chemotherapy volumes and stricter occupational safety regulations are important factors supporting market expansion. Hospitals, oncology centers, specialty clinics, and pharmacies are adopting CSTDs to improve workplace safety and establish controlled medication-handling procedures. Needleless systems currently account for a significant share because they can reduce sharps-related risks while supporting drug containment.

Technological advancements are also shaping the market. Diaphragm-based devices, compartmentalized systems, and automated pharmacy-compounding technologies are helping healthcare providers improve efficiency and consistency. Integration with robotic compounding systems and digital monitoring platforms could create additional opportunities for manufacturers.

Regionally, North America currently leads the market, while Asia-Pacific is expected to record rapid growth through 2035. Expanding oncology infrastructure, healthcare investments, and developing hazardous-drug handling standards are supporting adoption across emerging markets. Overall, rising safety awareness, regulatory requirements, and healthcare automation are expected to sustain the positive outlook for the CSTD market.